Sei Investments Co. Purchases 8,123 Shares of Agilent Technologies, Inc. (NYSE:A)

Sei Investments Co. lifted its position in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 493,294 shares of the medical research company’s stock after purchasing an additional 8,123 shares during the quarter. Sei Investments Co. owned 0.17% of Agilent Technologies worth $73,824,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. lifted its position in Agilent Technologies by 1.9% during the 3rd quarter. BlackRock Inc. now owns 32,943,190 shares of the medical research company’s stock worth $4,004,242,000 after buying an additional 629,153 shares in the last quarter. Vanguard Group Inc. lifted its position in Agilent Technologies by 1.0% during the 3rd quarter. Vanguard Group Inc. now owns 24,955,720 shares of the medical research company’s stock worth $3,033,368,000 after buying an additional 257,455 shares in the last quarter. State Street Corp lifted its position in Agilent Technologies by 0.6% during the 3rd quarter. State Street Corp now owns 13,152,295 shares of the medical research company’s stock worth $1,598,661,000 after buying an additional 73,495 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Agilent Technologies by 10.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,478,670 shares of the medical research company’s stock worth $787,483,000 after buying an additional 627,517 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its position in Agilent Technologies by 7.2% during the 4th quarter. Principal Financial Group Inc. now owns 3,341,738 shares of the medical research company’s stock worth $500,091,000 after buying an additional 223,008 shares in the last quarter.

Analyst Ratings Changes

A has been the topic of several recent analyst reports. Credit Suisse Group lowered their price objective on shares of Agilent Technologies from $170.00 to $160.00 and set an “outperform” rating on the stock in a research note on Wednesday. Robert W. Baird lowered their price objective on shares of Agilent Technologies from $174.00 to $144.00 and set an “outperform” rating on the stock in a research note on Wednesday. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Wednesday. 58.com reiterated a “maintains” rating on shares of Agilent Technologies in a research note on Wednesday. Finally, Evercore ISI decreased their price target on shares of Agilent Technologies from $150.00 to $126.00 and set an “outperform” rating on the stock in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $151.35.

Agilent Technologies Stock Down 0.1 %

Shares of Agilent Technologies stock traded down $0.17 during trading hours on Friday, reaching $119.32. The company’s stock had a trading volume of 403,288 shares, compared to its average volume of 1,520,395. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.53 and a current ratio of 2.37. The stock’s fifty day simple moving average is $133.52 and its two-hundred day simple moving average is $143.94. Agilent Technologies, Inc. has a one year low of $112.52 and a one year high of $160.26. The company has a market capitalization of $35.28 billion, a P/E ratio of 26.32, a P/E/G ratio of 1.79 and a beta of 1.03.

Agilent Technologies (NYSE:A – Get Rating) last released its quarterly earnings results on Tuesday, May 23rd. The medical research company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.01. Agilent Technologies had a net margin of 19.19% and a return on equity of 30.11%. The company had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm earned $1.13 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.63 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 26th. Investors of record on Monday, July 3rd will be issued a dividend of $0.225 per share. The ex-dividend date of this dividend is Friday, June 30th. This represents a $0.90 dividend on an annualized basis and a yield of 0.75%. Agilent Technologies’s dividend payout ratio (DPR) is presently 19.82%.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.